Tenderfy

Supply, Delivery, Installation, Commissioning and Post-Warranty Maintenance of Digital PCR (dPCR) System for Haemoto-oncology Assays

Acheteur
CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
Publié
2026-11-16
Échéance
2026-12-16T13:00:00+00:00
Sources
UK_FTS
Valeur
270000.0 GBP

Description

La description est dans la langue de la source.

The Cambridge Genomics Lab provides a comprehensive range of genomic testing for patients with haematological malignancies (haem-onc), with solid cancer, and with rare disease. In the haem-onc setting, we currently utilise a range of molecular techniques including Next-generation sequencing, quantitative PCR, and fragment analysis to identify and monitor clinically significant genomic alterations. However, there is an increasing requirement for high sensitivity, quantitative molecular testing both to support diagnosis and for disease monitoring / assessment of therapeutic response. We are therefore looking to procure a Digital / Digital Droplet (dPCR / ddPCR) system to complement the laboratory’s existing molecular testing capabilities. This would also intend to facilitate the consolidation of multiple existing assays and methodologies onto a single technology platform.

CPV: 38950000

Abonnement

Consultez gratuitement les aperçus. Les liens vers les avis officiels et leurs documents, les permis de construire et l’accès MCP personnel nécessitent un abonnement payant actif.

Lire